Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Feb;43(2):223-232.
doi: 10.1007/s10096-023-04702-w. Epub 2023 Nov 23.

Comparing ethanol lock therapy versus vancomycin lock in a salvation strategy for totally implantable vascular access device infections due to coagulase-negative staphylococci (the ETHALOCK study): a prospective double-blind randomized clinical trial

Olivier Lesens  1   2   3 , Emmanuel Forestier  4 , Elisabeth Botelho-Nevers  5 , Patricia Pavese  6 , Gary David  7 , Bertrand Nougarede  8 , Violaine Corbin  9 , Bruno Pereira  10 , Claire Aumeran  11 , Léo Sauvat  11
Affiliations
Randomized Controlled Trial

Comparing ethanol lock therapy versus vancomycin lock in a salvation strategy for totally implantable vascular access device infections due to coagulase-negative staphylococci (the ETHALOCK study): a prospective double-blind randomized clinical trial

Olivier Lesens et al. Eur J Clin Microbiol Infect Dis. 2024 Feb.

Abstract

Objectives: Little is known about efficacy and safety of ethanol lock therapy (ELT) to treat totally implantable venous access device (TIVAD) infections. The objective of this trial was to evaluate the effectiveness and safety profile of a local treatment with ELT without removal for TIVAD infection due to coagulase-negative staphylococci.

Methods: We performed a prospective, multicenter, double-blind, randomized clinical trial comparing the efficacy of 40% ELT versus vancomycin lock therapy (VLT) in TIVAD infections due to coagulase-negative staphylococci, complicated or not by bloodstream infection.

Results: Thirty-one patients were assigned to the ELT group and 30 to the VLT arm. Concomitant bacteremia was present in 41 patients (67.2%). Treatment success was 58.1 % (18 of 31) for the ELT arm and 46.7% (14 of 30) for the VLT arm (p = 0.37). The overall treatment success was 52.5% (32). The risk of treatment failure due to uncontrolled infections, superinfections, and mechanical complications did not differ significantly between participants receiving ELT (13 out of 31 [42%]) and those receiving VLT (16 out of 30 [53%]) with a hazard ratio of 0.70 (p = 0.343; 95% CI [0.34-1.46], Cox model). Catheter malfunctions were significantly more frequent in the ELT arm (11 patients versus 2 in the VLT group, p = 0.01).

Conclusions: We found an overall high rate of treatment failure that did not differ between the ELT arm and the VLT arm. TIVAD removal must be prioritized to prevent complications (uncontrolled infections, superinfections, and catheter malfunctions) except in exceptional situations.

Keywords: Central venous catheter infection; Coagulase-negative staphylococci; Ethanol; Lock solution; Totally implantable vascular access device; Vancomycin.

PubMed Disclaimer

References

    1. Walser EM (2012) Venous access ports: indications, implantation technique, follow-up, and complications. Cardiovasc Intervent Radiol 35:751–764. https://doi.org/10.1007/s00270-011-0271-2 - DOI - PubMed
    1. Pinelli F, Cecero E, Degl’Innocenti D, Selmi V, Giua R, Villa G, Chelazzi C, Romagnoli S, Pittiruti M (2018) Infection of totally implantable venous access devices: a review of the literature. J Vasc Access 19:230–242. https://doi.org/10.1177/1129729818758999 - DOI - PubMed
    1. Gapany C, Tercier S, Diezi M, Clement C, Lemay K, Joseph J-M (2011) Frequent accesses to totally implanted vascular ports in pediatric oncology patients are associated with higher infection rates. J Vasc Access 12:207–210. https://doi.org/10.5301/JVA.2011.6258 - DOI - PubMed
    1. Dibb M, Lal S (2017) Home parenteral nutrition: vascular access and related complications. Nutr Clin Pract 32:769–776. https://doi.org/10.1177/0884533617734788 - DOI - PubMed
    1. Wang TY, Lee KD, Chen PT, Chen MC, Chen YY, Huang CE, Kuan FC, Chen CC, Lu CH (2015) Incidence and risk factors for central venous access port-related infection in Chinese cancer patients. J Formos Med Assoc 114:1055–1060. https://doi.org/10.1016/j.jfma.2015.06.013 - DOI - PubMed

Publication types

LinkOut - more resources